Current trends in targeted therapies for glioblastoma multiforme
F Ohka, A Natsume… - Neurology research …, 2012 - Wiley Online Library
Glioblastoma multiforme (GBM) is one of the most frequently occurring tumors in the central
nervous system and the most malignant tumor among gliomas. Despite aggressive …
nervous system and the most malignant tumor among gliomas. Despite aggressive …
Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions
J Alexander, E Cukierman - Current opinion in cell biology, 2016 - Elsevier
Highlights•Innate mesenchymal-stroma maintains a tumor-suppressive homeostatic
equilibrium.•Fibroblastic-ECM interplay is referred to as stromal dynamic reciprocity.• …
equilibrium.•Fibroblastic-ECM interplay is referred to as stromal dynamic reciprocity.• …
Tumor evasion from T cell surveillance
K Töpfer, S Kempe, N Müller, M Schmitz… - BioMed Research …, 2011 - Wiley Online Library
An intact immune system is essential to prevent the development and progression of
neoplastic cells in a process termed immune surveillance. During this process the innate …
neoplastic cells in a process termed immune surveillance. During this process the innate …
Convection-enhanced delivery for the treatment of glioblastoma
MA Vogelbaum, MK Aghi - Neuro-oncology, 2015 - academic.oup.com
Effective treatment of glioblastoma (GBM) remains a formidable challenge. Survival rates
remain poor despite decades of clinical trials of conventional and novel, biologically …
remain poor despite decades of clinical trials of conventional and novel, biologically …
[HTML][HTML] Convection-enhanced delivery: connection to and impact of interstitial fluid flow
CA Stine, JM Munson - Frontiers in oncology, 2019 - frontiersin.org
Convection-enhanced delivery (CED) is a method used to increase transport of therapeutics
in and around brain tumors. CED works through locally applying a pressure differential to …
in and around brain tumors. CED works through locally applying a pressure differential to …
Targeting tumor cell motility to prevent metastasis
Mortality and morbidity in patients with solid tumors invariably result from the disruption of
normal biological function caused by disseminating tumor cells. Tumor cell migration is …
normal biological function caused by disseminating tumor cells. Tumor cell migration is …
Lessons from anti–vascular endothelial growth factor and anti–vascular endothelial growth factor receptor trials in patients with glioblastoma
Treatment of glioblastoma (GBM), the most common primary malignant brain tumor in adults,
remains a significant unmet need in oncology. Historically, cytotoxic treatments provided …
remains a significant unmet need in oncology. Historically, cytotoxic treatments provided …
[HTML][HTML] TGF-β signaling in bone remodeling and osteosarcoma progression
A Lamora, J Talbot, M Mullard… - Journal of clinical …, 2016 - mdpi.com
Osteosarcomas are the most prevalent malignant primary bone tumors in children. Despite
intensive efforts to improve both chemotherapeutics and surgical management, 40% of all …
intensive efforts to improve both chemotherapeutics and surgical management, 40% of all …
Tumor stroma as targets for cancer therapy
J Zhang, J Liu - Pharmacology & therapeutics, 2013 - Elsevier
Cancer is not only composed malignant epithelial component but also stromal components
such as fibroblasts, endothelial cells, and inflammatory cells, by which an appropriate tumor …
such as fibroblasts, endothelial cells, and inflammatory cells, by which an appropriate tumor …
Therapeutic potential of targeting micro RNA‐10b in established intracranial glioblastoma: first steps toward the clinic
NM Teplyuk, EJ Uhlmann, G Gabriely… - EMBO molecular …, 2016 - embopress.org
Abstract Micro RNA‐10b (miR‐10b) is a unique oncogenic mi RNA that is highly expressed
in all GBM subtypes, while absent in normal neuroglial cells of the brain. miR‐10b inhibition …
in all GBM subtypes, while absent in normal neuroglial cells of the brain. miR‐10b inhibition …